---
title: Hydroxyflutamide
slug: hydroxyflutamide
qid: 
snapshot: enwiki-001329020150
content_hash: 
license: CC BY-SA 4.0
source: https://en.wikipedia.org/w/index.php?oldid=1329020150
tags: [115142363, 23118434, 23468805, 23603337, 26220375, 28696559, 28697272, 28697656, 37750075, 43371251, 43884287, 50769796, 63007578, 67813784, 72504547, 73750311, 84373807]
---

# Hydroxyflutamide

> [!note] Provenance
> Snapshot `enwiki-001329020150` · content root `…`
> Derived from <https://en.wikipedia.org/w/index.php?oldid=1329020150> · Licensed CC BY-SA 4.0

Hydroxyflutamide (developmental code SCH-16423; also known as 2-hydroxyflutamide, HF, and OHF) is a nonsteroidal antiandrogen (NSAA) and the major active metabolite of flutamide, which is considered to be a prodrug of hydroxyflutamide as the active form. It has been reported to possess an IC 50 of 700 nM for the androgen receptor (AR), which is about 4-fold less than that of bicalutamide.

Hydroxyflutamide (developmental code SCH-16423; also known as 2-hydroxyflutamide, HF, and OHF) is a nonsteroidal antiandrogen (NSAA) and the major active metabolite of flutamide, which is considered to be a prodrug of hydroxyflutamide as the active form. It has been reported to possess an IC 50 of 700&nbsp;nM for the androgen receptor (AR), which is about 4-fold less than that of bicalutamide.
